Abstract Number: 867 • 2017 ACR/ARHP Annual Meeting
Highly Sensitive Cardiac Troponin-I in Peripheral Blood Predicts Cardiovascular Events in Patients with Rheumatoid Arthritis
Background/Purpose: Cardiac troponins (cTn) are specific biomarkers of myocardial injury; their measurement with highly-sensitive assays and at subthreshold levels for myocardial infarction (MI) diagnosis, predicts…Abstract Number: 869 • 2017 ACR/ARHP Annual Meeting
Utility of Carotid Ultrasound Compared to Framingham Risk Score in Predicting Cardiovascular Mortality in Rheumatoid Arthritis
Background/Purpose: Rheumatoid arthritis (RA) patients have a greater risk of cardiovascular (CV) mortality compared to general population. Traditional CV risk factors may be less accurate…Abstract Number: 872 • 2017 ACR/ARHP Annual Meeting
Myocardial Abnormalities Improve in RA Patients Treated Actively – a Cardiac MRI Follow-up Study
Background/Purpose: Patients with RA are prone to develop myocardial dysfunction, in which chronic inflammation is suggested to play an important role. We have previously shown…Abstract Number: 423 • 2016 ACR/ARHP Annual Meeting
Cardiovascular Risk and Lipid Screening in Rheumatoid Arthritis Patients in a University Rheumatology Practice: Quality Improvement Project
Background/Purpose: Meta-analyses of observational studies showed that RA patients’ morbidity and mortality risks stemming from cardiovascular (CV) causes were, respectively, close to 50% and 60%…Abstract Number: 1465 • 2016 ACR/ARHP Annual Meeting
Utility of Relative Cardiovascular Risk Score Scales in Patients UNDER the Age of 50 and Its Association with the Presence of Carotid Atherosclerosis in the Ultrasound
Background/Purpose: Rheumatoid Arthritis (RA) is associated with a greater cardiovascular mortality than the general population of the same age and gender. Cardiovascular events prediction scales,…Abstract Number: 1466 • 2016 ACR/ARHP Annual Meeting
Cardiovascular Risk Assessment in Persons with Rheumatoid Arthritis: A Correlative Study of Non-Invasive Arterial Health Testing with the Inflammatory Burden of Disease
Background/Purpose: Persons with rheumatoid arthritis (RA) have increased morbidity and mortality attributable to atherosclerotic cardiovascular disease (ASCVD) events. It is unknown how presence of subclinical…Abstract Number: 1472 • 2016 ACR/ARHP Annual Meeting
Comparison Between Carotid Plaque and Carotid Intima-Media Thickness to Detect Subclinical Atherosclerosis in Rheumatoid Arthritis
Background/Purpose: Carotid plaque (CP) detected by ultrasonography and carotid intima-media thickness (cIMT) are useful surrogate markers for subclinical atherosclerosis and good predictors of cardiovascular…Abstract Number: 1476 • 2016 ACR/ARHP Annual Meeting
Diastolic Dysfunction in Patients with Rheumatoid Arthritis: Predictors of Longitudinal Progression over Five Years
Background/Purpose: The impairment of left ventricular (LV) relaxation and passive filling, known as diastolic dysfunction, undergirds the development of heart failure in patients with…Abstract Number: 1491 • 2016 ACR/ARHP Annual Meeting
M-Ficolin and MAp44 As Potential Markers of Subclinical Cardiovascular Comorbidity; Cardiac Evaluation By Coronary Computer Tomography and Myocardial Deformation of Left Ventricle in Early Rheumatoid Arthritis Patients
Background/Purpose: 79 DMARD-naïve RA patients with a disease duration < 6 months were included from an inception cohort. Clinical variables, plasma- and serum-M-ficolin and MAp44…Abstract Number: 1990 • 2016 ACR/ARHP Annual Meeting
Increased Risk of Cardiovascular Events in Patients with Rheumatoid Arthritis over a 15 Year Time Period That Is Comparable to Type 2 Diabetes
Background/Purpose: recent cohort studies with long term follow up studying this risk are scarce.We report the results of a 15 year observational cohort study comparing…Abstract Number: 1298 • 2015 ACR/ARHP Annual Meeting
Advocating for Rheumatoid Arthritis and Cardiovascular Health (ARCH): A Collaborative and Systems-Based Approach to Improve Access to Care
Background/Purpose: Patients with rheumatoid arthritis (RA) have an increased risk of cardiovascular disease (CVD) as compared to the general population. The European League Against Rheumatism…Abstract Number: 2131 • 2015 ACR/ARHP Annual Meeting
Younger Age and Female Gender Are the Main Determinants of Underestimation of Cardiovascular Risk in Rheumatoid Arthritis Patients
Background/Purpose: Rheumatoid arthritis (RA) patients have an increased cardiovascular (CV) risk. Current algorithms generally underestimate the risk in these patients [1]. In a meta-analysis, we…Abstract Number: 1501 • 2015 ACR/ARHP Annual Meeting
Prevalence of Unassessed and Uncontrolled Cardiovascular Disease Risk Factors Among Rheumatoid Arthritis Patients in an Academic Rheumatology Practice
Background/Purpose: Cardiovascular disease (CVD) is the leading cause of death in individuals with rheumatoid arthritis (RA). Patients with RA are at 1.5-2.0-fold increased risk of…Abstract Number: 2630 • 2015 ACR/ARHP Annual Meeting
Rheumatoid Arthritis Patients with Carotid Plaque: 10-Year Follow-up
Background/Purpose: The main cause of mortality in patients with rheumatoid arthritis (RA) is atherosclerotic cardiovascular disease (ASCVD). RA patients have a 10-year decrease in life…Abstract Number: 1540 • 2015 ACR/ARHP Annual Meeting
Cardiovascular Risk Management in Rheumatoid Arthritis Patients
Background/Purpose: Rheumatoid arthritis (RA) patients have been previously shown to have a higher cardiovascular (CV) burden as compared to the general population. The CV risk…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 6
- Next Page »